HKUMed and Gleneagles Hospital Launch Groundbreaking Clinical Trials Centre
Innovative Clinical Trials Centre Established
The University of Hong Kong's Li Ka Shing Faculty of Medicine has successfully launched Hong Kong's first clinical trials centre in partnership with Gleneagles Hospital for cancer research. This facility will operate with greater flexibility than traditional public sector institutions, allowing for a streamlined process in clinical studies.
Advancing Oncology Research
Initially, the centre will focus on oncology, conducting trials for various cancer treatments. Dr. Wallace Lau Chak-sing emphasized the importance of this collaboration in enhancing medical research and improving patient outcomes in the region. He noted that the existing research expertise positions Hong Kong as a critical player in global health innovations.
Boosting Pharmaceutical Collaborations
- Commercial trials for cancer drugs
- Collaboration with NMPA for regulatory approval
- Potential for rapid testing of international drugs
Connecting local and international pharmaceutical companies is an essential aim of this initiative. Kenneth Tsang Hing-lim, CEO of Gleneagles, highlighted how this could pave the way for Hong Kong-drug approvals leading to entrance in the vast mainland market.
Disclaimer: The information provided on this site is for informational purposes only and is not intended as medical advice. We are not responsible for any actions taken based on the content of this site. Always consult a qualified healthcare provider for medical advice, diagnosis, and treatment. We source our news from reputable sources and provide links to the original articles. We do not endorse or assume responsibility for the accuracy of the information contained in external sources.
This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.